Skip to main content
Drug bottle and Pill

Compare Prandin vs. Invokana

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Repaglinide and canagliflozin (Invokana) are both medications used to treat Type 2 diabetes. However, they belong to different medication classes and have some important differences. Repaglinide is a meglitinide that stimulates the pancreas to release more insulin, helping to lower blood sugar levels. The typical dosage is a 0.5 mg to 4 mg oral tablet before each meal. In contrast, canagliflozin is an SGLT2 inhibitor that works by preventing sugar reabsorption in the kidneys, causing excess sugar to be eliminated through urine. It is taken once daily before the first meal of the day, with a starting dose of 100 mg. Repaglinide is available as a generic, while canagliflozin is only available as a brand-name medication. Common side effects of repaglinide include low blood sugar, headache, and diarrhea, whereas canagliflozin may cause yeast infections, urinary tract infections, and increased urination. Additionally, canagliflozin is FDA-approved to reduce the risk of major heart events and worsening kidney problems in some people with Type 2 diabetes.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.